CL2021000309A1 - Preparaciones farmacéuticas de sebacoilo dinalbufina y acetaminofén y métodos para tratar el dolor. - Google Patents
Preparaciones farmacéuticas de sebacoilo dinalbufina y acetaminofén y métodos para tratar el dolor.Info
- Publication number
- CL2021000309A1 CL2021000309A1 CL2021000309A CL2021000309A CL2021000309A1 CL 2021000309 A1 CL2021000309 A1 CL 2021000309A1 CL 2021000309 A CL2021000309 A CL 2021000309A CL 2021000309 A CL2021000309 A CL 2021000309A CL 2021000309 A1 CL2021000309 A1 CL 2021000309A1
- Authority
- CL
- Chile
- Prior art keywords
- acetaminophen
- methods
- pharmaceutical preparations
- treating pain
- sebacoyl dinalbuphine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2018/103786 WO2020047703A1 (en) | 2018-09-03 | 2018-09-03 | Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2021000309A1 true CL2021000309A1 (es) | 2021-07-19 |
Family
ID=69721971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2021000309A CL2021000309A1 (es) | 2018-09-03 | 2021-02-05 | Preparaciones farmacéuticas de sebacoilo dinalbufina y acetaminofén y métodos para tratar el dolor. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3846815A4 (ja) |
| JP (2) | JP7318987B2 (ja) |
| KR (1) | KR102700501B1 (ja) |
| CN (1) | CN113164469A (ja) |
| AU (1) | AU2018440280B2 (ja) |
| CA (1) | CA3111271A1 (ja) |
| CL (1) | CL2021000309A1 (ja) |
| IL (1) | IL280822A (ja) |
| SG (1) | SG11202101974WA (ja) |
| WO (1) | WO2020047703A1 (ja) |
| ZA (1) | ZA202102209B (ja) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237140A (en) * | 1979-05-18 | 1980-12-02 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and acetaminophen |
| US6225321B1 (en) * | 1997-06-05 | 2001-05-01 | Oliver Yoa-Pu Hu | Long analgesic acting nalbuphine polyester derivative and method of use |
| AU2003296954A1 (en) | 2002-12-13 | 2004-07-09 | The Regents Of The University Of California | Analgesic combination comprising nalbuphine |
| EP1964552B1 (en) * | 2007-03-02 | 2009-08-26 | Flamek Corp OÜ | Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids |
| LT3069733T (lt) | 2013-11-13 | 2022-11-25 | National Defense Education And Research Foundation | Nauja acetaminofeno junginio sudėtis be šalutinio poveikio kepenims |
-
2018
- 2018-09-03 CN CN201880096947.3A patent/CN113164469A/zh active Pending
- 2018-09-03 CA CA3111271A patent/CA3111271A1/en active Pending
- 2018-09-03 AU AU2018440280A patent/AU2018440280B2/en active Active
- 2018-09-03 WO PCT/CN2018/103786 patent/WO2020047703A1/en unknown
- 2018-09-03 SG SG11202101974WA patent/SG11202101974WA/en unknown
- 2018-09-03 KR KR1020217009905A patent/KR102700501B1/ko active IP Right Grant
- 2018-09-03 JP JP2021536123A patent/JP7318987B2/ja active Active
- 2018-09-03 EP EP18932827.1A patent/EP3846815A4/en active Pending
-
2021
- 2021-02-05 CL CL2021000309A patent/CL2021000309A1/es unknown
- 2021-02-11 IL IL280822A patent/IL280822A/en unknown
- 2021-03-31 ZA ZA2021/02209A patent/ZA202102209B/en unknown
-
2023
- 2023-04-03 JP JP2023060264A patent/JP2023078480A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023078480A (ja) | 2023-06-06 |
| JP7318987B2 (ja) | 2023-08-01 |
| SG11202101974WA (en) | 2021-03-30 |
| EP3846815A1 (en) | 2021-07-14 |
| IL280822A (en) | 2021-04-29 |
| AU2018440280A1 (en) | 2021-03-18 |
| CN113164469A (zh) | 2021-07-23 |
| AU2018440280B2 (en) | 2022-11-03 |
| JP2021535216A (ja) | 2021-12-16 |
| ZA202102209B (en) | 2022-03-30 |
| KR20210054560A (ko) | 2021-05-13 |
| CA3111271A1 (en) | 2020-03-12 |
| KR102700501B1 (ko) | 2024-08-28 |
| EP3846815A4 (en) | 2022-05-04 |
| WO2020047703A1 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
| ECSP19043710A (es) | Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas | |
| CL2020002043A1 (es) | Métodos y composiciones para la entrega de proteínas terapeuticas. | |
| EA201891083A1 (ru) | Составы антител к cd38 для подкожного введения и их применение | |
| CO2018013077A2 (es) | Inhibidores de la arginasa y sus aplicaciones terapéuticas | |
| ECSP21093541A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados con braf | |
| EA201791874A1 (ru) | Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение | |
| EA201990598A1 (ru) | Высококонцентрированные низковязкие препараты ингибирующего masp-2 антитела, наборы и способы | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
| CL2018000622A1 (es) | Acetamida tienodiazepinas de triazol y sus usos relacionados. | |
| EA201991073A1 (ru) | Ингибиторы magl | |
| CL2021001395A1 (es) | Compuestos derivados de panteteínas cíclicas; composición farmacéutica que los comprende; y su uso para aumentar las concentraciones de acetil-coa, para el tratamiento de cáncer, enfermedad inflamatoria, enfermedad neurodegenerativa, esclerosis múltiple, entre otras enfermedades. | |
| EA201991074A1 (ru) | Ингибиторы magl | |
| BR112019024566A2 (pt) | inibidores de pirazol magl | |
| EA201891468A1 (ru) | Композиции и способы для снижения экспрессии tau | |
| CO2019002889A2 (es) | Tratamientos de combinación que comprenden la administración de imidazopirazinonas | |
| CL2019001586A1 (es) | Insulina que contiene composiciones farmacéuticas. | |
| PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
| EA201892265A1 (ru) | Способы лечения офтальмологических заболеваний | |
| EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
| CL2019001053A1 (es) | Formulaciones farmacéuticas y métodos para prepararlas. | |
| CL2022000967A1 (es) | Composiciones y métodos para el tratamiento de enfermedades hepáticas | |
| EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| CL2018000430A1 (es) | Compuesto de hidroxitriazina y uso médico relacionado. |